Exclusion of patients with psychiatric disorders from early phase oncology trials: A limited access to innovation?

被引：0
|
作者：
Matte, P. [1 ]
Delaye, M. [1 ]
Mc Govern, A. [2 ]
Ouali, K. [3 ]
Danlos, F-X. [3 ]
Henon, C. [1 ]
Goldschmidt, V. [3 ]
Mahjoubi, L. [1 ]
Hollebecque, A. [3 ]
Michot, J-M. [3 ]
Gazzah, A. [3 ]
Bahleda, R. [3 ]
Smolenschi, C. [3 ]
Marabelle, A. [3 ]
Champiat, S. [3 ]
Loriot, Y. [3 ]
Aix, S. Ponce [3 ]
Rouby, P. [4 ]
Lemogne, C. [5 ]
Baldini, C. [1 ]
机构：
[1] Inst Gustave Roussy, Drug Dev Dept, Villejuif, France
[2] Hop Robert Debre, AP HP, Psychiat Enfant & Adolescent, Paris, France
[3] Gustave Roussy, Drug Dev Dept DITEP, Canc Campus, Villejuif, France
[4] Gustave Roussy, Psychiat, Villejuif, France
[5] Grp Hosp Hotel Dieu, AP HP, Psychiat, Paris, France
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2796
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1845P
引用
收藏
页码：S999 / S1000
页数：2
相关论文
共 50 条
  • [1] Exclusion of patients with psychiatric disorders from early phase oncology trials: A limited access to innovation?
    Matte, Paul
    Delaye, Matthieu
    Mc Govern, Alice
    Rouby, Pascal
    Ponce, Santiago
    Lemogne, Cedric
    Baldini, Capucine
    GENERAL HOSPITAL PSYCHIATRY, 2024, 87 : 164 - 165
  • [2] Impact of Early Access Reform on Oncology Innovation in France: Approvals, Patients, and Costs
    Martin, Tess
    Rioufol, Catherine
    Favier, Bertrand
    Martelli, Nicolas
    Madelaine, Isabelle
    Chouaid, Christos
    Borget, Isabelle
    BIODRUGS, 2024, 38 (03) : 465 - 475
  • [3] Access to innovation through the national early access program and clinical trials for patients with malignant melanoma
    Christen, Claire
    Belgodere, Laetitia
    Guillot, Bernard
    Jumeau, Celine
    Lorence, Annie
    Kerouani-Lafaye, Ghania
    Brunel, Liora
    Turcry, Florence
    Monard, Adrien
    Grude, Francoise
    Guyader, Gaelle
    Boudali, Lotfi
    Albin, Nicolas
    CANCER, 2021, 127 (13) : 2262 - 2270
  • [4] Unnecessary exclusion: Eligibility criteria in gynecologic oncology interventional clinical trials impair access to trials
    Holtzman, Sharonne
    Letchinger, Riva
    Liu, Daniel
    Singh, Sunidhi
    Zamarin, Dmitriy
    Zakashansky, Konstantin
    Blank, Stephanie
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S449 - S449
  • [5] Is the exclusion of psychiatric patients from access to physician-assisted suicide discriminatory?
    Hatherley, Joshua James
    JOURNAL OF MEDICAL ETHICS, 2019, 45 (12) : 817 - 820
  • [6] ELIGIBILITY CRITERIA OF EARLY PHASE ONCOLOGY TRIALS
    Hohmann, N.
    Hilse, K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S20 - S20
  • [7] Evolution of early phase clinical trials in oncology
    Nam Q. Bui
    Shivaani Kummar
    Journal of Molecular Medicine, 2018, 96 : 31 - 38
  • [8] Evolution of early phase clinical trials in oncology
    Bui, Nam Q.
    Kummar, Shivaani
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2018, 96 (01): : 31 - 38
  • [9] Economic growth of BRIC nations and access to early-phase oncology clinical trials: An overview
    Rodrigues, Heloisa Veasey
    Ganesan, Prasanth
    Liu, Xiaochun
    Subbiah, Vivek
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [10] INTELLECTUAL DISABILITY AND PSYCHIATRIC DISORDERS AS EXCLUSION CRITERIA IN RANDOMIZED CONTROLLED TRIALS (RCT)
    Camanni, Guido
    Ciccone, Ornella
    Lepri, Alessandro
    Tinarelli, Chiara
    Menna, Marina
    Baglioni, Antonella
    Murgia, Nicola
    Elisei, Sandro
    PSYCHIATRIA DANUBINA, 2021, 33 : 36 - 39
12345